Completed
Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease
NCT04817670
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- Investigator Site 709 Birmingham, Alabama, United States
- Investigator Site 708 Los Angeles, California, United States
- Investigator Site 713 Aurora, Colorado, United States
- Investigator Site 706 Hollywood, Florida, United States